BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 5771314)

  • 1. Platelet adhesiveness in polycythaemai rubra vera.
    Shield LK; Pearn JH
    Med J Aust; 1969 Apr; 1(14):711-5. PubMed ID: 5771314
    [No Abstract]   [Full Text] [Related]  

  • 2. Abnormalities of platelet function in patients with polycythemia vera.
    Berger S; Aledort LM; Gilbert HS; Hanson JP; Wasserman LR
    Cancer Res; 1973 Nov; 33(11):2683-7. PubMed ID: 4748429
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple thromboses in polycythemia vera.
    Mork JN; Barlow JF
    Minn Med; 1978 Apr; 61(4):209-10. PubMed ID: 642903
    [No Abstract]   [Full Text] [Related]  

  • 4. Laboratory investigations and prediction of thrombotic risk in polycythemia vera.
    Boneu B
    Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):183-5. PubMed ID: 8036139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet aggregation and platelet factor 3 activity in myeloproliferative disorders.
    Tangün Y
    Thromb Diath Haemorrh; 1971 Jun; 25(2):241-51. PubMed ID: 5284903
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in hemostasis during polycythemia vera (review and personal contribution)].
    Tucci G; Facchini G; Spagna I; Masiello O; Cremonini GP
    Arch Patol Clin Med; 1968 Nov; 45(1):3-29. PubMed ID: 5737487
    [No Abstract]   [Full Text] [Related]  

  • 7. [Case of crural ulcer during polycythemia vera].
    Trevisan G; Ponte E
    Minerva Med; 1976 Jul; 67(34):2229-32. PubMed ID: 951047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood coagulation in polycythaemia vera.
    Nagy G; Aszódi L; Hatvani I; Antal L
    Acta Med Acad Sci Hung; 1968; 25(2):157-60. PubMed ID: 5728889
    [No Abstract]   [Full Text] [Related]  

  • 9. Haemostatic defects in polycythaemia vera.
    Stathakis NE; Papayannis AG; Arapakis G; Gardikas C
    Blut; 1974 Aug; 29(2):77-86. PubMed ID: 4852216
    [No Abstract]   [Full Text] [Related]  

  • 10. The haematocrit and platelet target in polycythemia vera.
    Di Nisio M; Barbui T; Di Gennaro L; Borrelli G; Finazzi G; Landolfi R; Leone G; Marfisi R; Porreca E; Ruggeri M; Rutjes AW; Tognoni G; Vannucchi AM; Marchioli R;
    Br J Haematol; 2007 Jan; 136(2):249-59. PubMed ID: 17156406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycythemia vera in the childbearing age.
    Harris RE; Conrad FG
    Arch Intern Med; 1967 Dec; 120(6):697-700. PubMed ID: 6058404
    [No Abstract]   [Full Text] [Related]  

  • 12. Thromboelastographic studies in polycythaemia vera.
    Nagy G; Siró B; Rácz M
    Acta Med Acad Sci Hung; 1969; 26(3):271-4. PubMed ID: 5379130
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fibrinolysis studied by an in vitro clot lysis test in polycythemia vera].
    Pósán E; Ujj G; Kiss A; Telek B; Rák K; Udvardy M
    Orv Hetil; 1996 Jan; 137(2):71-4. PubMed ID: 8721871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycythemia vera and transient monocular blindness. Observation of the platelet embolic phenomena in the ocular fundus.
    Kuriyama M; Ishii N; Umezaki H; Kano M
    Eur Neurol; 1977; 16(1-6):127-35. PubMed ID: 615704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between increased hematopoiesis and saturation of iron storage in polycythemia rubra vera].
    Nagy G; Dezsö I; Varsányi M; Léhi M
    Orv Hetil; 1975 Apr; 116(14):790-1. PubMed ID: 1118148
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thrombotic and hemorrhagic complications in polycythemia vera].
    Indrák K; Hrcková Y; Scudla V
    Vnitr Lek; 1986 Mar; 32(3):272-8. PubMed ID: 3962210
    [No Abstract]   [Full Text] [Related]  

  • 17. Platelet malonyldialdehyde and spontaneous aggregation during ischaemic attacks of patients with polycythaemia vera.
    Cortelazzo S; Barbui T; Viero P; Bassan R; Dini E; Ferro Milone F
    Thromb Haemost; 1979 Dec; 42(4):1344-6. PubMed ID: 542939
    [No Abstract]   [Full Text] [Related]  

  • 18. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
    Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of antithrombin III, protein C, and protein S levels and activated protein C resistance in polycythemia vera and essential thrombocythemia patients with thrombosis.
    Bucalossi A; Marotta G; Bigazzi C; Galieni P; Dispensa E
    Am J Hematol; 1996 May; 52(1):14-20. PubMed ID: 8638606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential thrombocythemia following polycythemia vera: an unusual sequence.
    Randi ML; Barbone E; Zerbinati P; Soini B; Rossi C; Girolami A
    J Med; 1996; 27(5-6):363-8. PubMed ID: 9151204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.